申请人:Gilead Sciences, Inc.
公开号:US08884030B2
公开(公告)日:2014-11-11
Provided are compounds of Formula I:
and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections.
提供的是公式I的化合物及其药用可接受的盐和酯。这些化合物、组合物和方法可用于治疗黄病毒科病毒感染,特别是丙型肝炎感染。